188 related articles for article (PubMed ID: 37058447)
21. The human cytomegalovirus IE2 and UL112-113 proteins accumulate in viral DNA replication compartments that initiate from the periphery of promyelocytic leukemia protein-associated nuclear bodies (PODs or ND10).
Ahn JH; Jang WJ; Hayward GS
J Virol; 1999 Dec; 73(12):10458-71. PubMed ID: 10559364
[TBL] [Abstract][Full Text] [Related]
22. Genetic and epigenetic modifications of Sox2 contribute to the invasive phenotype of malignant gliomas.
Alonso MM; Diez-Valle R; Manterola L; Rubio A; Liu D; Cortes-Santiago N; Urquiza L; Jauregi P; Lopez de Munain A; Sampron N; Aramburu A; Tejada-Solís S; Vicente C; Odero MD; Bandrés E; García-Foncillas J; Idoate MA; Lang FF; Fueyo J; Gomez-Manzano C
PLoS One; 2011; 6(11):e26740. PubMed ID: 22069467
[TBL] [Abstract][Full Text] [Related]
23. Cytomegalovirus infection induces a stem cell phenotype in human primary glioblastoma cells: prognostic significance and biological impact.
Fornara O; Bartek J; Rahbar A; Odeberg J; Khan Z; Peredo I; Hamerlik P; Bartek J; Stragliotto G; Landázuri N; Söderberg-Nauclér C
Cell Death Differ; 2016 Feb; 23(2):261-9. PubMed ID: 26138445
[TBL] [Abstract][Full Text] [Related]
24. The Human Cytomegalovirus IE1 Protein Antagonizes PML Nuclear Body-Mediated Intrinsic Immunity via the Inhibition of PML De Novo SUMOylation.
Schilling EM; Scherer M; Reuter N; Schweininger J; Muller YA; Stamminger T
J Virol; 2017 Feb; 91(4):. PubMed ID: 27903803
[TBL] [Abstract][Full Text] [Related]
25. Modulation of oncogenic phenotype in human glioma cells by cytomegalovirus IE1-mediated mitogenicity.
Cobbs CS; Soroceanu L; Denham S; Zhang W; Kraus MH
Cancer Res; 2008 Feb; 68(3):724-30. PubMed ID: 18245472
[TBL] [Abstract][Full Text] [Related]
26. General blockade of human cytomegalovirus immediate-early mRNA expression in the S/G2 phase by a nuclear, Daxx- and PML-independent mechanism.
Zydek M; Uecker R; Tavalai N; Stamminger T; Hagemeier C; Wiebusch L
J Gen Virol; 2011 Dec; 92(Pt 12):2757-2769. PubMed ID: 21832009
[TBL] [Abstract][Full Text] [Related]
27. Stimulation of the Replication of ICP0-Null Mutant Herpes Simplex Virus 1 and pp71-Deficient Human Cytomegalovirus by Epstein-Barr Virus Tegument Protein BNRF1.
Lu Y; Orr A; Everett RD
J Virol; 2016 Nov; 90(21):9664-9673. PubMed ID: 27535048
[TBL] [Abstract][Full Text] [Related]
28. Xihuang Pill-destabilized CD133/EGFR/Akt/mTOR cascade reduces stemness enrichment of glioblastoma via the down-regulation of SOX2.
Xu L; Duan H; Zou Y; Wang J; Liu H; Wang W; Zhu X; Chen J; Zhu C; Yin Z; Zhao X; Wang Q
Phytomedicine; 2023 Jun; 114():154764. PubMed ID: 36963368
[TBL] [Abstract][Full Text] [Related]
29. Proteasome-independent disruption of PML oncogenic domains (PODs), but not covalent modification by SUMO-1, is required for human cytomegalovirus immediate-early protein IE1 to inhibit PML-mediated transcriptional repression.
Xu Y; Ahn JH; Cheng M; apRhys CM; Chiou CJ; Zong J; Matunis MJ; Hayward GS
J Virol; 2001 Nov; 75(22):10683-95. PubMed ID: 11602710
[TBL] [Abstract][Full Text] [Related]
30. Inhibiting DNA-PK induces glioma stem cell differentiation and sensitizes glioblastoma to radiation in mice.
Fang X; Huang Z; Zhai K; Huang Q; Tao W; Kim L; Wu Q; Almasan A; Yu JS; Li X; Stark GR; Rich JN; Bao S
Sci Transl Med; 2021 Jun; 13(600):. PubMed ID: 34193614
[TBL] [Abstract][Full Text] [Related]
31. Arsenic trioxide disrupts glioma stem cells via promoting PML degradation to inhibit tumor growth.
Zhou W; Cheng L; Shi Y; Ke SQ; Huang Z; Fang X; Chu CW; Xie Q; Bian XW; Rich JN; Bao S
Oncotarget; 2015 Nov; 6(35):37300-15. PubMed ID: 26510911
[TBL] [Abstract][Full Text] [Related]
32. SOX2-RNAi attenuates S-phase entry and induces RhoA-dependent switch to protease-independent amoeboid migration in human glioma cells.
Oppel F; Müller N; Schackert G; Hendruschk S; Martin D; Geiger KD; Temme A
Mol Cancer; 2011 Nov; 10():137. PubMed ID: 22070920
[TBL] [Abstract][Full Text] [Related]
33. Human cytomegalovirus immediate-early gene expression is restricted by the nuclear domain 10 component Sp100.
Adler M; Tavalai N; Müller R; Stamminger T
J Gen Virol; 2011 Jul; 92(Pt 7):1532-1538. PubMed ID: 21471311
[TBL] [Abstract][Full Text] [Related]
34. Activation of estrogen receptor beta signaling reduces stemness of glioma stem cells.
Sareddy GR; Pratap UP; Venkata PP; Zhou M; Alejo S; Viswanadhapalli S; Tekmal RR; Brenner AJ; Vadlamudi RK
Stem Cells; 2021 May; 39(5):536-550. PubMed ID: 33470499
[TBL] [Abstract][Full Text] [Related]
35. Small ubiquitin-related modifier (SUMO) pathway-mediated enhancement of human cytomegalovirus replication correlates with a recruitment of SUMO-1/3 proteins to viral replication compartments.
Scherer M; Reuter N; Wagenknecht N; Otto V; Sticht H; Stamminger T
J Gen Virol; 2013 Jun; 94(Pt 6):1373-1384. PubMed ID: 23407422
[TBL] [Abstract][Full Text] [Related]
36. Cytomegalovirus immediate-early 1 proteins form a structurally distinct protein class with adaptations determining cross-species barriers.
Schweininger J; Scherer M; Rothemund F; Schilling EM; Wörz S; Stamminger T; Muller YA
PLoS Pathog; 2021 Aug; 17(8):e1009863. PubMed ID: 34370791
[TBL] [Abstract][Full Text] [Related]
37. ID4 imparts chemoresistance and cancer stemness to glioma cells by derepressing miR-9*-mediated suppression of SOX2.
Jeon HM; Sohn YW; Oh SY; Kim SH; Beck S; Kim S; Kim H
Cancer Res; 2011 May; 71(9):3410-21. PubMed ID: 21531766
[TBL] [Abstract][Full Text] [Related]
38. Dual inhibition of Src and PLK1 regulate stemness and induce apoptosis through Notch1-SOX2 signaling in EGFRvIII positive glioma stem cells (GSCs).
Li X; Tao Z; Wang H; Deng Z; Zhou Y; Du Z
Exp Cell Res; 2020 Nov; 396(1):112261. PubMed ID: 32896567
[TBL] [Abstract][Full Text] [Related]
39. Differential relocation and stability of PML-body components during productive human cytomegalovirus infection: detailed characterization by live-cell imaging.
Dimitropoulou P; Caswell R; McSharry BP; Greaves RF; Spandidos DA; Wilkinson GW; Sourvinos G
Eur J Cell Biol; 2010 Oct; 89(10):757-68. PubMed ID: 20599291
[TBL] [Abstract][Full Text] [Related]
40. Evidence for a dual antiviral role of the major nuclear domain 10 component Sp100 during the immediate-early and late phases of the human cytomegalovirus replication cycle.
Tavalai N; Adler M; Scherer M; Riedl Y; Stamminger T
J Virol; 2011 Sep; 85(18):9447-58. PubMed ID: 21734036
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
